A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)

Clinical trial NCT02584543 · COMPLETED

Trial details

NCT number: NCT02584543
Sponsor: Xiamen Innovax Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis E Hepatitis B

Start date: 2015-10-01
Primary completion: 2016-08-25
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.